Thrombolex filed an amendment to its SEC Form D to reveal that the company sold nearly $10 million in a debt offering. The New Britain, Pa.-based company made the first sale in the offering of debt and convertible promissory notes on April 6, 2017. No issuer size was disclosed for the offering, which included contributions […]